Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
S-309309 by Shionogi for Obesity: Likelihood of Approval
S-309309 is under clinical development by Shionogi and currently in Phase II for Obesity. According to GlobalData, Phase II drugs...
Risk adjusted net present value: What is the current valuation of Shionogi's S-309309?
S-309309 is commercialized by Shionogi, with a leading Phase II program in Obesity. According to Globaldata, it is involved in...
S-309309 by Shionogi for Obesity: Likelihood of Approval
S-309309 is under clinical development by Shionogi and currently in Phase II for Obesity. According to GlobalData, Phase II drugs...